{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:09:08Z","timestamp":1769126948171,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Clinical Electrophysiology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jacep.2021.03.006","type":"journal-article","created":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T03:21:20Z","timestamp":1615692080000},"page":"685-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Point\/Counterpoint on Halting Implantation of the Subcutaneous ICD"],"prefix":"10.1016","volume":"7","author":[{"given":"John","family":"Mandrola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan","family":"Enache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raul","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emile G.","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacep.2021.03.006_bib1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2021.03.006_bib3","series-title":"Important Medical Device Advisory","year":"2020"},{"key":"10.1016\/j.jacep.2021.03.006_bib4","article-title":"Transvenous implantable cardioverter-defibrillator (ICD) lead performance: a meta-analysis of observational studies","volume":"4","author":"Provid\u00eancia","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacep.2021.03.006_bib6","first-page":"677","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"384","author":"Kim","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2021.03.006_bib7","first-page":"678","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"384","author":"Knops","year":"2021","journal-title":"Reply. N Engl J Med"},{"key":"10.1016\/j.jacep.2021.03.006_bib8","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jacc.2015.11.026","article-title":"Safety and efficacy of the subcutaneous implantable defibrillator","volume":"67","author":"Lewis","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacep.2021.03.006_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.hrthm.2019.10.024","article-title":"Defibrillation failure in patients undergoing replacement of subcutaneous defibrillator pulse generator","volume":"17","author":"Rudic","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jacep.2021.03.006_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ahj.2012.02.012","article-title":"Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy","volume":"163","author":"Olde Nordkamp","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacep.2021.03.006_bib11","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMc2034917","article-title":"Subcutaneous or transvenous defibrillator therapy","volume":"384","author":"Mandrola","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2021.03.006_bib12","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa071098","article-title":"Prognostic importance of defibrillator shocks in patients with heart failure","volume":"359","author":"Poole","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2021.03.006_bib13","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacep.2021.03.006_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/CIRCULATIONAHA.120.048728","article-title":"Primary results from the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) trial","volume":"143","author":"Gold","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jacep.2021.03.006_bib15","doi-asserted-by":"crossref","first-page":"1901e6","DOI":"10.1001\/jama.295.16.1901","article-title":"Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports","volume":"295","author":"Maisel","year":"2006","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1016\/j.jacep.2021.03.006_bib16","first-page":"s94","article-title":"Myocardial voltage gradients produced by subcutaneous, substernal and transvenous ICD shock (abstr)","volume":"14","author":"Heist","year":"2017","journal-title":"Heart Rhythm"}],"container-title":["JACC: Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X21002188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405500X21002188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:29:24Z","timestamp":1762500564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405500X21002188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2405500X21002188"],"URL":"https:\/\/doi.org\/10.1016\/j.jacep.2021.03.006","relation":{},"ISSN":["2405-500X"],"issn-type":[{"value":"2405-500X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Point\/Counterpoint on Halting Implantation of the Subcutaneous ICD","name":"articletitle","label":"Article Title"},{"value":"JACC: Clinical Electrophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacep.2021.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}